Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
May identify TNF superfamily members as therapeutic targets in calcific aortic valve disease; leaves open the need for interventional trials.
Calcific aortic valve disease (CAVD) represents a slowly progressive pathologic process associated with major morbidity and mortality. The process is characterized by multiple steps: inflammation, fibrosis, and calcification. Numerous studies focalized on its physiopathology highlighting different "actors" for the multiple "acts." This paper focuses on the role of the tumor necrosis factor superfamily (TNFSF) members in the pathogenesis of CAVD. In particular, we discuss the clinical and experimental studies providing evidence of the involvement of tumor necrosis factor-alpha (TNF-α), receptor activator of nuclear factor-kappa B (NF-κB) ligand (RANKL), its membrane receptor RANK and its decoy receptor osteoprotegerin (OPG), and TNF-related apoptosis-inducing ligand (TRAIL) in valvular calcification.
No takes yet. Share an insight, caveat, or question.
Galeone et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: